NJBIZ - Pharma and Life Sciences http://www.njbiz.com/section/pharma_lifescience Pharma and Life Sciences Pharma and Life Sciences en-us Copyright 2015 NJBIZ Thu, 03 Sep 2015 22:43:17 EST Thu, 03 Sep 2015 22:43:17 EST http://www.njbiz.com/article/20150903/NJBIZ01/150909925&source=RSS Princeton drugmaker fetches 1.23B in sale to Philly company A Philadelphia generic drugmaker has agreed to buy a Princeton-based specialty generic pharmaceutical company for 1. 23 billion, it announced. Thu, 03 Sep 2015 12:34:00 EST http://www.njbiz.com/article/20150903/NJBIZ01/150909925&source=RSS http://www.njbiz.com/article/20150903/NJBIZ01/150909932&source=RSS Integra LifeSciences to acquire two products from Tornier Plainsboro-based Integra LifeSciences Holdings Corporation announced Thursday that it will acquire the rights to Amsterdam-based Tornier&#8217s ankle and toe replacement products. Thu, 03 Sep 2015 10:04:00 EST http://www.njbiz.com/article/20150903/NJBIZ01/150909932&source=RSS http://www.njbiz.com/article/20150901/NJBIZ01/150909988&source=RSS Biopharma company names former Rutgers professor to its management team Bedminster-based biopharmaceutical company Matinas BioPharma Holdings Inc. has named a former Rutgers University professor as its new senior vice president and chief technology officer, it announced Tuesday. Tue, 01 Sep 2015 10:23:00 EST http://www.njbiz.com/article/20150901/NJBIZ01/150909988&source=RSS http://www.njbiz.com/article/20150831/NJBIZ01/150839968&source=RSS Vision Real Estate, Mill Creek Residential pair up to revamp Bayer campus in Montville Vision Real Estate Partners has teamed with a well-known multifamily builder to redevelop a former Bayer HealthCare office park in Montville, where it plans to renovate one building while seeking new zoning for a residential component on the remainder of the site. Mon, 31 Aug 2015 14:02:00 EST http://www.njbiz.com/article/20150831/NJBIZ01/150839968&source=RSS http://www.njbiz.com/article/20150831/NJBIZ01/308319999&source=RSS Big pharma still a force in Jersey's office market For a company that knows how to grab headlines, last week was no different for Valeant Pharmaceuticals International Inc. Mon, 31 Aug 2015 11:09:00 EST http://www.njbiz.com/article/20150831/NJBIZ01/308319999&source=RSS http://www.njbiz.com/article/20150831/NJBIZ01/150839982&source=RSS Cranbury biotech company buys N.C. biopharma firm focused on rare diseases Cranbury-based biotech Amicus Therapeutics is paying 229 million for Scioderm Inc. , a biopharmaceutical company focused on diseases with high unmet need. Mon, 31 Aug 2015 10:27:00 EST http://www.njbiz.com/article/20150831/NJBIZ01/150839982&source=RSS http://www.njbiz.com/article/20150831/NJBIZ01/150839984&source=RSS South Plainfield device maker creates Israeli unit South Plainfield-based medical device maker Vention Medical said Monday it is opening a site in Israel near Tel Aviv to support the region's growing device market. Mon, 31 Aug 2015 10:04:00 EST http://www.njbiz.com/article/20150831/NJBIZ01/150839984&source=RSS http://www.njbiz.com/article/20150828/NJBIZ01/150829776&source=RSS Generic topical maker buys Vineland building IGI Laboratories Inc. is expanding its headquarters with the acquisition of a building in Vineland, according to real estate firm Wolf Commercial Real Estate. Fri, 28 Aug 2015 11:41:00 EST http://www.njbiz.com/article/20150828/NJBIZ01/150829776&source=RSS http://www.njbiz.com/article/20150828/NJBIZ01/150829791&source=RSS Celgene wraps up 7.2B deal for Receptos Celgene Corporation announced Thursday it has completed the previously announced acquisition of biopharmaceutical company Receptos Inc. Fri, 28 Aug 2015 09:41:00 EST http://www.njbiz.com/article/20150828/NJBIZ01/150829791&source=RSS http://www.njbiz.com/article/20150827/NJBIZ01/150829815&source=RSS Halo Pharmaceuticals adds to management team Whippany-based Halo Pharmaceutical announced Thursday that it has appointed Lee Karras CEO and Barry Lederman chief financial officer. Thu, 27 Aug 2015 09:33:00 EST http://www.njbiz.com/article/20150827/NJBIZ01/150829815&source=RSS http://www.njbiz.com/article/20150826/NJBIZ01/150829836&source=RSS Princeton pharmaceutical company appoints Del Buono CFO and VP of finance Adare Pharmaceuticals Inc. announced Wednesday that it has appointed Joseph Del Buono chief financial officer and vice president, finance. Wed, 26 Aug 2015 12:12:00 EST http://www.njbiz.com/article/20150826/NJBIZ01/150829836&source=RSS http://www.njbiz.com/article/20150826/NJBIZ01/150829837&source=RSS BD acquires Cellular Research to develop leading genomics platform for single cell analysis Franklin Lakes-based BD Lifes Sciences announced Wednesday it has completed its acquisition of Cellular Research Inc. Wed, 26 Aug 2015 12:03:00 EST http://www.njbiz.com/article/20150826/NJBIZ01/150829837&source=RSS http://www.njbiz.com/article/20150825/NJBIZ01/150829872&source=RSS Amneal creates biosciences subsidiary, names pharmacy veteran to lead it Generic drugmaker Amneal Pharmaceuticals LLC has created a new biosciences subsidiary, it announced Tuesday. Tue, 25 Aug 2015 12:55:00 EST http://www.njbiz.com/article/20150825/NJBIZ01/150829872&source=RSS http://www.njbiz.com/article/20150824/NJBIZ01/150829907&source=RSS Valeant doubles office space in Bridgewater, to 620K sq. ft. Valeant Pharmaceuticals International Inc. has leased another 310,000 square feet at Somerset Corporate Center in Bridgewater, doubling its footprint at the SJP Properties-owned complex less than two years after establishing its U. S. headquarters there. Mon, 24 Aug 2015 11:47:00 EST http://www.njbiz.com/article/20150824/NJBIZ01/150829907&source=RSS http://www.njbiz.com/article/20150820/NJBIZ01/150829980&source=RSS Valeant paying 1B for maker of first FDA-approved female sexual-dysfunction drug On Tuesday, Sprout Pharmaceuticals Inc. won approval for its female sexual-dysfunction drug, Addyi. On Thursday, the company got a new owner Valeant Pharmaceuticals International Inc. Thu, 20 Aug 2015 09:46:00 EST http://www.njbiz.com/article/20150820/NJBIZ01/150829980&source=RSS http://www.njbiz.com/article/20150819/NJBIZ01/150819752&source=RSS FDA approval of female sexual-dysfunction drug gives N.J. company optimism When North Carolina-based Sprout Pharmaceuticals' Addyi became the first drug to treat low sexual desire in women to be approved the FDA, it received cheers from an unlikely source the competition. Wed, 19 Aug 2015 13:50:00 EST http://www.njbiz.com/article/20150819/NJBIZ01/150819752&source=RSS http://www.njbiz.com/article/20150819/NJBIZ01/150819757&source=RSS Cortex Pharmaceuticals appoints CEO Cortex Pharmaceuticals Inc. announced Wednesday that Dr. James S. Manuso has been appointed CEO, president, vice chairman and member of the board of directors. Wed, 19 Aug 2015 12:56:00 EST http://www.njbiz.com/article/20150819/NJBIZ01/150819757&source=RSS http://www.njbiz.com/article/20150819/NJBIZ01/150819760&source=RSS Danish pharmaceutical company shutting Paramus operations A corporate restructuring means the closure of the Lundbeck Research USA Inc. facility in Paramus, costing 68 workers their jobs. Wed, 19 Aug 2015 12:40:00 EST http://www.njbiz.com/article/20150819/NJBIZ01/150819760&source=RSS http://www.njbiz.com/article/20150819/NJBIZ01/150819768&source=RSS Parsippany pharma firm names chief medical officer Parsippany-based specialty pharmaceutical company Pacira Pharmaceuticals Inc. said Wednesday it has named a new chief medical officer to oversee the clinical research and development for expanded uses of its products. Wed, 19 Aug 2015 09:42:00 EST http://www.njbiz.com/article/20150819/NJBIZ01/150819768&source=RSS http://www.njbiz.com/article/20150818/NJBIZ01/150819799&source=RSS Zoetis signs 12-year lease for Parsippany office building owned by Normandy Zoetis, the animal health company spun off from Pfizer in 2013, will relocate its global headquarters to Parsippany from Florham Park in a deal with Normandy Real Estate Partners. Tue, 18 Aug 2015 09:41:00 EST http://www.njbiz.com/article/20150818/NJBIZ01/150819799&source=RSS